First up is a Phase 2 clinical trial in patients with geographic atrophy, the advanced stage of dry age-related macular degeneration, that should launch …



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *